Abrams, Julian A.

Proton pump inhibitors alter the composition of the gut microbiota

Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 895

Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial

Freedberg, D. E., Toussaint, N. C., Chen, S. P., Ratner, A. J., Whittier, S., Wang, T. C., Wang, H. H., & Abrams, J. A. (2015) · Gastroenterology

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 322

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Horvath, A., Rainer, F., Bashir, M., Leber, B., Schmerboeck, B., Klymiuk, I., Groselj-Strele, A., Durdevic, M., Freedberg, D. E., Abrams, J. A., et al. (2019) · Scientific Reports

Gut microbiota and healthLiver Disease and Transplantation

Cited by 93

Barrett's esophagus is associated with a distinct oral microbiome

Snider, E. J., Compres, G., Freedberg, D. E., Giddins, M. J., Khiabanian, H., Lightdale, C. J., Nobel, Y. R., Toussaint, N. C., Uhlemann, A.-C., & Abrams, J. A. (2018) · Clinical and Translational Gastroenterology

Oral microbiology and periodontitis researchGut microbiota and health

Cited by 72

The microbiome as a potential biomarker for oesophageal adenocarcinoma

Abrams, J. A. (2017) · The Lancet Gastroenterology & Hepatology

Esophageal Cancer Research and TreatmentGut microbiota and health

Cited by 7